ENOV
Overvalued by 178.8% based on the discounted cash flow analysis.
Market cap | $2.27 Billion |
---|---|
Enterprise Value | $3.72 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.61 |
Beta | 2.01 |
Outstanding Shares | 54,855,810 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -24.65 |
---|---|
PEG | 110.7 |
Price to Sales | 0.8 |
Price to Book Ratio | 0.67 |
Enterprise Value to Revenue | 1.73 |
Enterprise Value to EBIT | -4.61 |
Enterprise Value to Net Income | -5 |
Total Debt to Enterprise | 0.4 |
Debt to Equity | 0.57 |
No data
No data
Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...